Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cells
- 25 October 2007
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 364 (4), 778-782
- https://doi.org/10.1016/j.bbrc.2007.10.067
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Integrated molecular profiling of SOD2 expression in multiple myelomaBlood, 2006
- Expression of CD200 on Epithelial Cells of the Murine Hair Follicle: A Role in Tissue-Specific Immune Tolerance?Journal of Investigative Dermatology, 2004
- Role of regulatory and suppressor T-cells in the induction of ILT3+ ILT4+ tolerogenic endothelial cells in organ allograftsTransplant Immunology, 2004
- Identification of a cancer stem cell in human brain tumors.2003
- The effect of bone-associated growth factors and cytokines on the growth of prostate cancer cells derived from soft tissue versus bone metastases in vitro.International Journal of Oncology, 2003
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- The 3C Protease Activity of Enterovirus 71 Induces Human Neural Cell ApoptosisVirology, 2002
- Down-Regulation of the Macrophage Lineage Through Interaction with OX2 (CD200)Science, 2000
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997
- A cell initiating human acute myeloid leukaemia after transplantation into SCID miceNature, 1994